- Home
- GPRK vs THW Comparison
GPRK vs THW Comparison
Compare GPRK & THW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Company Overview
Basic Information| Metric | GPRK | THW |
|---|---|---|
| Founded | 2002 | N/A |
| Country | Colombia | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Finance Companies |
| Sector | Energy | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 629.3M | 513.9M |
| IPO Year | 2009 | 2015 |
Fundamental Metrics
Financial Performance| Metric | GPRK | THW |
|---|---|---|
| Price | $9.60 | $12.71 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $8.50 | N/A |
| AVG Volume (30 Days) | ★ 552.1K | 89.7K |
| Earning Date | 05-06-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.26% | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $39.45 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $12.70 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.75 | $10.10 |
| 52 Week High | $10.34 | $13.19 |
Technical Indicators
Market Signals| Indicator | GPRK | THW |
|---|---|---|
| Relative Strength Index (RSI) | 53.19 | 53.29 |
| Support Level | $7.87 | $12.33 |
| Resistance Level | $10.18 | $12.84 |
| Average True Range (ATR) | 0.33 | 0.16 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 65.45 | 55.28 |
Price Performance
Historical ComparisonAbout GPRK Geopark Ltd
GeoPark Ltd is an independent energy company. Its diversified portfolio of assets consist of Llanos 34 Block in Colombia, CPO-5 Block, Llanos 86, Llanos 87, Llanos 104, Llanos 123, and Llanos 124 Blocks in the Llanos Basin. Its segments include Colombia, Argentina, Brazil and Ecuador, with the majority of the revenue derived from Colombia. It derives revenue from Sale of crude oil, Sale of purchased crude oil, and Sale of gas.
About THW abrdn World Healthcare Fund Shares of Beneficial Interest
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.